Table 3.
Comparison of MDCT findings with ER and HER2 status
| ER+/HER2− | ER+/HER2+ | ER−/HER2− | ER−/HER2+ | |
|---|---|---|---|---|
| Tumor shape | ||||
| Well | 23 | 5 | 24* | 9* |
| Moderate | 169* | 12 | 20 | 13 |
| Poorly | 110* | 8 | 8 | 8 |
| Scattered | 25 | 4 | 5 | 1 |
| Enhancement pattern | ||||
| Homogenous | 142 | 10 | 14 | 14 |
| Heterogenous | 162 | 16 | 26 | 15 |
| Rim | 8 | 2 | 12* | 2 |
| Poor | 15 | 1 | 3 | 0 |
| Density | ||||
| High | 198 | 21 | 20 | 22 |
| Intermediate/low | 129 | 8 | 35* | 9 |
*Higher ratio P < 0.05. ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; MDCT, multidetector row helical computed tomography; +, positive; −, negative.